<?xml version="1.0" encoding="UTF-8"?>
<p id="p0070">In general terms, optimal disease management is still being debated, and the therapeutic approach still lacks significant evidence. The indication for antiretroviral therapy is uncertain, and to date there are no approved drugs for the treatment of SARS-CoV-2 infection.
 <xref rid="bib5" ref-type="bibr">
  <sup>5</sup>
 </xref> Although anecdotal experience can be drawn from the use of antiviral agents on viruses belonging to the same family of Betacoronaviruses (SARS and Middle East respiratory syndrome), the current COVID-19 pandemic requires the identification of effective therapies. To date, no clear guidelines exist for the management of these patients in general and for hemodialysis and transplant patients in particular.
 <xref rid="bib6" ref-type="bibr">
  <sup>6</sup>
 </xref>
</p>
